#adult

  1. Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment
  2. Prevention of erectile dysfunction - Sign of a good prognosis after acute myocardial infarction
  3. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations
  4. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
  5. Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: Escitalopram vs paroxetine
  6. Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
  7. Escitalopram maintenance treatment for prevention of recurrent depression: A randomized, placebo-controlled trial
  8. Two items on the Hamilton Depression rating scale are effective predictors of remission: Comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine
  9. Fixed-dose trial of the single isomer SSRI Escitalopram in depressed outpatients
  10. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo